Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.12.2023 | Case report

Cabozantinib

Thyroiditis

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bulchandani S, et al. A Case of Thyroiditis Cause by Cabozantinib. Journal of the Endocrine Society 7 (Suppl.): A1038-A1039, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.1953 [abstract] Bulchandani S, et al. A Case of Thyroiditis Cause by Cabozantinib. Journal of the Endocrine Society 7 (Suppl.): A1038-A1039, Nov 2023. Available from: URL: https://dx.doi.org/10.1210/jendso/bvad114.1953 [abstract]
Metadaten
Titel
Cabozantinib
Thyroiditis
Publikationsdatum
01.12.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-50899-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Pueraria

Case report

Multiple drugs

Case report

Brodalumab

Case report

Prednisolone

Case report

Multiple drugs

Case report

Evolocumab